Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Cell Lysis via Selective Viral Replication (Oncolytic Virotherapy)
- Target
- Oncolytic Virotherapy
- Molecular classification
- Virus, Immunotherapy
01
Overview
Tumor cell lysis via selective viral replication refers to the process by which certain viruses, known as oncolytic viruses (OVs), are engineered or naturally possess the ability to preferentially infect, replicate within, and destroy cancer cells while sparing normal tissues. This approach leverages the unique vulnerabilities of tumor cells to achieve targeted cytolysis and stimulate anti-tumor immunity.
- Other names
- Oncolytic virus therapyOV therapySelective viral replicationVirotherapy
02
Mechanism of action
Selective replication in tumor cells, direct oncolysis, and stimulation of anti-tumor immunity.
03
Biological functions
Tumor cell lysisImmune response stimulationCell deathAntigen releaseDanger signal release
04
Disease associations
Cancer
05
Safety considerations
Off-target effectsImmune-related adverse eventsPotential for viral sheddingPre-existing immunity to the virus
06
Interacting drugs
Talimogene laherparepvec (T-VEC)
07
Biomarkers
Tumor typeViral replication markersImmune response markers (e.g., T cell infiltration)
Beyond the preview
Go deeper on Tumor Cell Lysis via Selective Viral Replication (Oncolytic Virotherapy).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Cell Lysis via Selective Viral Replication (Oncolytic Virotherapy).